201 related articles for article (PubMed ID: 35373571)
1. SARS-CoV-2 vaccine, a new autoimmune hepatitis trigger?
López Romero-Salazar F; Veras Lista M; Gómez-Domínguez E; Ibarrola-Andrés C; Muñoz Gómez R; Fernández Vázquez I
Rev Esp Enferm Dig; 2022 Sep; 114(9):567-568. PubMed ID: 35373571
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune liver diseases and SARS-CoV-2.
Sgamato C; Rocco A; Compare D; Minieri S; Marchitto SA; Maurea S; Nardone G
World J Gastroenterol; 2023 Mar; 29(12):1838-1851. PubMed ID: 37032727
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.
Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW
United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
Kang SH; Kim MY; Cho MY; Baik SK
J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccine and autoimmune hepatitis.
Sookaromdee P; Wiwanitkit V
Rev Esp Enferm Dig; 2022 Oct; 114(10):631. PubMed ID: 35469403
[TBL] [Abstract][Full Text] [Related]
6. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
Ghielmetti M; Schaufelberger HD; Mieli-Vergani G; Cerny A; Dayer E; Vergani D; Terziroli Beretta-Piccoli B
J Autoimmun; 2021 Sep; 123():102706. PubMed ID: 34293683
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid-refractory autoimmune hepatitis after COVID-19 vaccination: a case report and literature review.
Ueno M; Takabatake H; Itakura J; Fujita R; Kayahara T; Morimoto Y; Notohara K; Mizuno M
Clin J Gastroenterol; 2023 Aug; 16(4):554-558. PubMed ID: 37029249
[TBL] [Abstract][Full Text] [Related]
8. First report of post-transplant autoimmune hepatitis recurrence following SARS-CoV-2 mRNA vaccination.
Mahalingham A; Duckworth A; Griffiths WJH
Transpl Immunol; 2022 Jun; 72():101600. PubMed ID: 35390478
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome].
Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
Avci E; Abasiyanik F
J Autoimmun; 2021 Dec; 125():102745. PubMed ID: 34781161
[TBL] [Abstract][Full Text] [Related]
11. Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics.
Uzun S; Zinner CP; Beenen AC; Alborelli I; Bartoszek EM; Yeung J; Calgua B; Reinscheid M; Bronsert P; Stalder AK; Haslbauer JD; Vosbeck J; Mazzucchelli L; Hoffmann T; Terracciano LM; Hutter G; Manz M; Panne I; Boettler T; Hofmann M; Bengsch B; Heim MH; Bernsmeier C; Jiang S; Tzankov A; Terziroli Beretta-Piccoli B; Matter MS
J Hepatol; 2023 Sep; 79(3):666-676. PubMed ID: 37290592
[TBL] [Abstract][Full Text] [Related]
12. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
[TBL] [Abstract][Full Text] [Related]
13. Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features.
Wen M; Men R; Fan X; Shen Y; Ni P; Hu Z; Yang L
Dig Dis; 2021; 39(4):366-374. PubMed ID: 33238269
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune hepatitis after COVID-19 vaccination.
Zheng H; Zhang T; Xu Y; Lu X; Sang X
Front Immunol; 2022; 13():1035073. PubMed ID: 36505482
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis.
Kobayashi M; Kakuda Y; Harada K; Sato Y; Sasaki M; Ikeda H; Terada M; Mukai M; Kaneko S; Nakanuma Y
World J Gastroenterol; 2014 Apr; 20(13):3597-608. PubMed ID: 24707143
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
Vuille-Lessard É; Montani M; Bosch J; Semmo N
J Autoimmun; 2021 Sep; 123():102710. PubMed ID: 34332438
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hepatitis after SARS-C¬¬oV-2 vaccination.
Díez Ruiz S; Quiñones Castro R; Alcoba Vega L; Martín Izquierdo A; González Puente I; Rodríguez Martín L; Díez Rodríguez R; Jorquera Plaza F
Rev Esp Enferm Dig; 2023 Jul; 115(7):406. PubMed ID: 37114399
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
Zeng Z; Han YK; Zhang XF; Geng H
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480
[TBL] [Abstract][Full Text] [Related]
19. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.
Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E
Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205
[TBL] [Abstract][Full Text] [Related]
20. A Case of Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome during Treatment with Brodalumab for Generalized Pustular Psoriasis.
Okazaki S; Hoashi T; Saeki H; Kanda N
J Nippon Med Sch; 2021; 88(6):569-573. PubMed ID: 34980743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
